Covid-19: where we are now
Infections and hospitalisations continue to rise as a highly contagious new Covid subvariant spreads rapidly across the UK
Covid-19 infections and hospitalisations are on the rise in the UK and more than 100,000 Britons are at risk of developing long Covid in the coming weeks, scientists have warned.
The latest hospital figures showed a 20% jump in daily admissions in the week to 22 December, according to the NHS, with experts warning that Covid infection numbers could hit record numbers in the UK.
The figures come amid warnings from volunteer Covid variant trackers that a new, highly mutated Covid variant, JN.1, could become as impactful as Omicron, the last Covid strain to have been issued a Greek letter by the World Health Organisation (WHO).
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
How much of a threat is JN.1?
In late 2021, in the wake of the deadly Delta wave of infections, a new variant came "flying in out of left field", said Fortune. Omicron was "so highly mutated, so drastically different that it changed the trajectory of the Covid-19 pandemic", with Covid and Omicron becoming "all but synonymous".
Now, the new variant JN.1, has achieved similar global dominance, but whether WHO will recognise it with a Greek letter "remains to be seen", Fortune said. As of today, the international health body still has not done so – and "some experts say that's a mistake".
JN.1, appears to be "especially adept at infecting those who have been vaccinated or previously infected", said the Washington Post. It is also the currently the fastest-growing variant in the United States, according to the US Centres for Disease Control and Prevention, accounting for 15-29% of infections.
While highly contagious, the JN.1 subvariant – which is also sweeping the UK – "is not thought to be any more severe than other recent Covid variants", said the i newspaper. However, reduced levels of vaccinations in the past two years "have increased the risk of serious symptoms when people become infected", the paper added.
Dr Maria Van Kerkhove, an expert on infectious diseases, who leads the WHO's Department for Epidemic and Pandemic Preparedness and Prevention told Sky News that vaccinating at-risk people needs to remain a priority globally.
"The vaccination coverage in all countries of the at-risk groups is abysmal," she told the broadcaster. "For me, this is the biggest frustration. Covid-19 actually has solutions […] that can prevent severe disease and death. Why aren't we using them?"
What is the risk posed by long Covid?
A new UK Health Security Agency (UKHSA) national influenza and Covid report released last week, confirmed that Covid cases and hospitalisations have risen since the last updates just before Christmas, prompting "fears of a sharp rise in long Covid in the coming weeks", said the i newspaper.
Professor Lawrence Young, a virologist at Warwick University, told the paper that the current wave of Covid "will inevitably result in thousands of new cases of long Covid".
"Vaccination against Covid reduces the severity and duration of long Covid," Young said. "But restricted access to the latest booster jab – only the over 65s, clinical vulnerable and healthcare workers are eligible – means that many people are more likely to suffer the acute and long-term effects of Covid."
Is Covid a 'winter bug'?
Covid cases last year peaked in December. But experts have cautioned against assuming that the coronavirus will follow the pattern of other respiratory infections and become a winter illness.
Although transmission increases as people mix indoors during the colder months, the same is also true in very hot weather, as people head inside to escape the heat.
"It seems like patterns of waning [immunity] and the evolution of [the] virus itself are still the main drivers for the sort of variation that we're seeing," said Professor Steven Riley, director general of data, analytics and surveillance at UKHSA, speaking to The Guardian in October. "[Covid] doesn't seem to have dropped into any kind of resonance with seasonal factors."
However, with pressure increasing on the health service over the winter period, NHS England is urging eligible people to get flu and Covid jabs to avoid a potential "twindemic".
Should we be wearing masks again?
The UK and many other countries have "moved to a position of 'living with the virus' without investing in testing, ventilation and infrastructure changes, and masking", wrote immunologist Sheena Cruickshank, a professor in biomedical sciences at Manchester University, in The Guardian.
But "add to this that vaccine coverage and access to boosters is quite limited, and there’s a recipe for many Covid infections – and a greater likelihood of the virus changing".
The question of whether to mask again is a "complicated" one, said Simon Clarke, associate professor in cellular microbiology at Reading University.Masking was introduced in the UK in 2020, as part of a wide package of measures.
Yet masks "did not prevent subsequent waves of infections and lockdowns", Clarke said in an article on The Conversation this August. "It seems unlikely that masking on its own, without other measures, would have much effect, if any."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
Mary Poppins tour: 'humdinger' of a show kicks off at Bristol Hippodrome
The Week Recommends Stefanie Jones and Jack Chambers are 'true triple threats' as Mary and Bert in 'timeless' production
By Irenie Forshaw, The Week UK Published
-
Jaguar's stalled rebrand
In the spotlight Critics and car lovers are baffled by the luxury car company's 'complete reset'
By Abby Wilson Published
-
What the chancellor's pension megafund plans mean for your money
Rachel Reeves wants pension schemes to merge and back UK infrastructure – but is it putting your money at risk?
By Marc Shoffman, The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
No more bugging: how Egypt became certified malaria-free
Under the radar It was a century-long effort
By Devika Rao, The Week US Published
-
Why scurvy is on the rise
The Explainer Cost of living and poor dietary choices fuelling a potential resurgence of condition associated with the Age of Sail
By Richard Windsor, The Week UK Published
-
How Britain's demographic is changing
The Explainer A 50-year record population increase was fuelled by greater migration
By Richard Windsor, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
The 'game-changing' treatment for schizophrenia
The Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
By Harriet Marsden, The Week UK Published
-
The audio industry is working to tackle hearing aid stigma
The Explainer Only 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of America
By Justin Klawans, The Week US Published
-
Psychedelic drugs and treating mental illness
The Explainer Scientists claim hallucinogenics could help treat depression and anxiety, but not everyone is convinced
By Elizabeth Carr-Ellis, The Week UK Published